Good MorningThe S&P 500 closed the day on Friday with a gain of 0.30% to end at another all-time closing high. The move was driven by a rise in optimism despite the rising number of COVID-19 cases but may be short-lived. While the index moved up to set a new closing high there is still resistance at the all-time intraday high. Until the market moves above that level bullish traders should be cautious.
Next week will bring another round of important economic data that could move the market. Topping the list is the monthly Non-Farm Payroll report and unemployment figures. The risk for the market is that an unexpected uptick in jobless claims in November may point to weaker than expected NFP numbers. Until then there is a raft of other data including the Fed’s Beige Book for investors to consider.
Featured: Shocking Video Reveals The Near-Perfect Trading Strategy (True Market Insiders) 
|
Markets | | | Global stock markets were mixed Friday as questions about the effectiveness of one possible coronavirus vaccine weighed on investor optimism.
Markets in London and Sydney declined while Frankfurt, Shanghai and Hong Kong gained.
Investor optimism about progress in vacci... Read the Full Story |
|
|
Stocks | | |
There are different approaches to growing a portfolio. Some investors like to focus on high-flying technology stocks to generate capital appreciation. Others prefer to get their growth in a steadier fashion by investing in companies that have a history of increasing their dividend payments.
Here ... Read the Full Story |
|
Politics | | | Over four decades, Mary Nichols has been the regulator behind some of the nation’s most ambitious climate policies and, in recent years, she’s been their staunchest defender against President Donald Trump's effort to dismantle them.
With Joe Biden heading to the White House, Nichols h... Read the Full Story |
|
From Our PartnersIt trades under a secret name...for just $3.
But thanks to a developing situation involving Donald Trump, America's No. 1 tech company and $10 billion...this may soon be the most talked-about stock in America. | | Find out more about the "secret stock" here. |
|
Politics | | | Lawmakers in Taiwan got into a fist fight and threw pig guts at each other Friday over a soon-to-be enacted policy that would allow imports of U.S. pork and beef.
Premier Su Tseng-chang was due to give a regularly scheduled policy report to lawmakers on Friday morning about the pork p... Read the Full Story |
|
Politics | | | North Korean leader Kim Jong Un has ordered at least two people executed, banned fishing at sea and locked down the capital, Pyongyang, as part of frantic efforts to guard against the coronavirus and its economic damage, South Korea’s spy agency told lawmakers Friday.
Kim's government... Read the Full Story |
|
From Our PartnersThis hidden income strategy was just leaked and it can be yours now. It goes in depth about how you can start off with a small account and turn that into your own weekly paycheck. Learn how you can GAIN that extra advantage over what others aren't doing. | | Click here to get this secret |
|
Politics | | | North Korean leader Kim Jong Un has ordered at least two people executed, banned fishing at sea and locked down capital Pyongyang as part of frantic efforts to guard against the coronavirus and its economic damage, South Korea’s spy agency told lawmakers Friday.
Kim's government also ... Read the Full Story |
|
Markets | | |
The Dow hit 30,000 for the first time yesterday and the S&P 500 surged more than 1.6%. But this wasn’t a day where there was green across the board.
Many of yesterday’s winners were companies that have struggled during the pandemic, but expect to turn it around once a vaccine beco... Read the Full Story |
|
Stocks | | |
While much of the media attention in the health care space has been around COVID-19 treatments and vaccines, several companies that aren't involved in those areas have quietly gone about their business to produce impressive growth. These three health care leaders are all finding ways to generate g... Read the Full Story |
|
Markets | | |
For a while now Best Buy (NYSE: BBY), the $30 billion electronics retailer, has been pinned as one of the better-performing retailers in 2020, a year that has forced many to adapt or die. Coming into yesterday’s release, shares were not only up more than 150% since March, but trading at all-... Read the Full Story |
|
Markets | | | Satellite radio provider Sirius XM Holdings Inc. (NASDAQ: SIRI) stock was hit hard by the pandemic but shares are creeping back towards it pre-COVID levels. As the restart initiative continues to accelerate with improving auto sales, SiriusXM has the momentum to accelerate its growth with a larger b... Read the Full Story |
|
The Early Bird Stock Of The Day Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; and OP-1250 combine with CDK4/6 inhibitors palbociclib, ribociclib, and alpelisib in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer, as well as develops OPERA-01 for the of ER+/HER2- advanced or metastatic breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. | | View Today's Stock Pick |
|
